Samsrita Labs
SAMSRITA · Retail > Trading Listing date: Aug. 11, 2015

Stock Price vs Company Growth
1d
2.8%
1w
5.5%
1m
7.3%
3m
11.7%
6m
34.6%
1y
33.2%
5y
16.8%
10y
5.1%
all
0.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 13 2.8%
11.2
19
Company Overview

Sales
0.02 Cr
Growth: -4.4%
Profit after Tax
-9.05 Cr
Growth: 4.6%
Micro Cap
29.5 Cr
P/S: 1640.5x
Industry P/S: 1.4x
Fundamentals

Sales (Cr) ₹ 0.02
Growth -4.4%
EBITDA N/A
P/S 1640.5x
Dividend 0.0%
P/E N/A
Book Value ₹ 10
PEG Ratio N/A
ROE -43.6%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Dr Habeebullah Life Sciences with its group Companies has established platforms in the areas of Stem Cell Research and Therapy, New Drug Discovery, Molecular Prognosis and Diagnostics services, CRO, Stem Cell focused Super Specialty Hospital, RNA Interference Technology and Medical Devices.
Investors (4)